Metformin and cancer: solutions to a real-world evidence failure
OHY Yu, S Suissa - Diabetes care, 2023 - Am Diabetes Assoc
The quest to repurpose metformin, an antidiabetes drug, as an agent for cancer prevention
and treatment, which began in 2005 with an observational study that reported a reduction in …
and treatment, which began in 2005 with an observational study that reported a reduction in …
Anticarcinogenic Effects of Gold Nanoparticles and Metformin Against MCF-7 and A549 Cells
Metformin is commonly prescribed to people with diabetes. Metformin has been shown in
previous studies to be able to prevent the growth of cancer cells. This study aims to …
previous studies to be able to prevent the growth of cancer cells. This study aims to …
Preoperative metabolic syndrome and prognosis after pancreatectomy for pancreatic cancer: A retrospective study
F Gu, X Shen, Z Wang, Z Xie, N Ke - World Journal of Surgery, 2024 - Wiley Online Library
Background We conducted a retrospective study to investigate the impact of metabolic
syndrome (MetS), its individual components, and the number of metabolic risk factors on the …
syndrome (MetS), its individual components, and the number of metabolic risk factors on the …
[HTML][HTML] Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome
JS Park, SJ Moon, HS Park, SH Cho - Preventive Medicine Reports, 2024 - Elsevier
Abstract Background Metabolic syndrome (MetSyn) is a disease cluster causing
cardiovascular disease, cancer, and high mortality. Metformin is the most common …
cardiovascular disease, cancer, and high mortality. Metformin is the most common …
Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor-infiltrating lymphocytes in an experimental carcinoma model
HM Zaki, KM Ali, MYY Abd Allah, AM Abouelnaga… - BMC Research …, 2024 - Springer
Metformin is a widely used antidiabetic biguanide. Retrospective data demonstrated the
association of metformin use with survival benefit in multiple tumor types. Interest in …
association of metformin use with survival benefit in multiple tumor types. Interest in …
Association of metformin and statin uses with the prognosis of colon cancer: a meta-analysis
Y Xu, H Che, J Liu, P Ye - European Journal of Cancer Prevention, 2024 - journals.lww.com
Background Metformin and statins are commonly used globally for the treatment of type 2
diabetes mellitus and dyslipidemia, respectively. Recently, multiple novel pathways have …
diabetes mellitus and dyslipidemia, respectively. Recently, multiple novel pathways have …
二甲双胍在恶性肿瘤治疗中的研究进展
段雪玉， 廖彬彬， 李蕾， 张鼎才， 陈瑞祥… - 中国 …, 2024 - journal.china-pharmacy.com
近年来二甲双胍潜在的抗肿瘤效果在肿瘤治疗领域引起了广泛关注. 本文综述了二甲双胍在恶性
肿瘤治疗中的研究进展, 发现其在消化系统恶性肿瘤(胆道癌, 胃癌, 食管癌, 结直肠癌, 胰腺癌 …
肿瘤治疗中的研究进展, 发现其在消化系统恶性肿瘤(胆道癌, 胃癌, 食管癌, 结直肠癌, 胰腺癌 …
Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model
S Manickavel, Y Hartman, A Burns… - Otology & …, 2023 - journals.lww.com
Background There have been reported associations between patients with VS prescribed
metformin and decreased tumor volumetric growth. Aspirin has also been associated with …
metformin and decreased tumor volumetric growth. Aspirin has also been associated with …
Research progress on metformin in the treatment for malignant tumors
D Xueyu, L Binbin, LI Lei, Z Dingcai… - China …, 2024 - journal.china-pharmacy.com
In recent years, the potential anti-tumor effects of metformin have attracted widespread
attention in the field of cancer treatment. This article summarizes the research progress of …
attention in the field of cancer treatment. This article summarizes the research progress of …